Adaptin Bio, Inc. Deferred Tax Assets, Tax Deferred Expense, Other
Adaptin Bio, Inc. (APTN) had Deferred Tax Assets, Tax Deferred Expense, Other of $3.13 thousand as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2024-04-01
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $3.13K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other |
|---|---|
| 2023-12-31 | $3.13K 10-K · filed 2024-04-01 |